From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project

Background. Polysaccharide vaccines had been used to control African meningitis epidemics for >30 years but with little or modest success, largely because of logistical problems in the implementation of reactive vaccination campaigns that are begun after epidemics are under way. After the major g...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguado, M. Teresa, Jodar, Luis, Granoff, Dan, Rabinovich, Regina, Ceccarini, Costante, Perkin, Gordon W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639495/
https://www.ncbi.nlm.nih.gov/pubmed/26553665
http://dx.doi.org/10.1093/cid/civ593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639495/
https://www.ncbi.nlm.nih.gov/pubmed/26553665
http://dx.doi.org/10.1093/cid/civ593

Ejemplares similares